Disclosures for "Exploring Conversations of Genetic Risk in Latino Families With Huntington’s Disease (HD)"
-
Ms. Shammas has received personal compensation for serving as an employee of Arrowhead Pharmaceuticals. Ms. Shammas has received personal compensation for serving as an employee of Architect Therapeutics.
-
Ms. Tobar has nothing to disclose.
-
Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Clinical Education Alliance. Dr. Mendizabal has received research support from Huntington's Disease Society of America. Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Huntington's Disease Society of America (HDSA).
-
Ms. Dorrani has nothing to disclose.
-
Mrs. Fox has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Invitae/LabCorp.
-
Dr. Sayegh has nothing to disclose.